Suppr超能文献

蒽环类糖苷和博来霉素在沙门氏菌检测系统中的致突变性。

Mutagenicity of anthracycline glycosides and bleomycins in Salmonella assay system.

作者信息

Umezawa K, Haresaku M, Muramatsu M, Matsushima T

机构信息

Institute of Microbial Chemistry, Tokyo.

出版信息

Biomed Pharmacother. 1987;41(5):214-8.

PMID:2444280
Abstract

Aclacinomycin A was nonmutagenic, while most anthracycline drugs such as daunomycin and adriamycin are highly mutagenic in a Salmonella test. But its derivative, N-demethylaclacinomycin A, was mutagenic. Similarly, aclavin, a hydrolysis product of aclacinomycin A, was nonmutagenic, but N-demethylaclavin was mutagenic. N-Methyldaunomycin showed only weak mutagenicity, and N-dimethyldaunomycin was nonmutagenic. Thus, the amino moiety of anthracycline glycosides is concluded to be essential for mutagenesis. Bleomycins were nonmutagenic to most Salmonella tester strains such as TA98, TA100 and TA92 and also to a Escherichia coli strain WP2/uvrA. Bleomycins were weakly mutagenic to Salmonella TA102 and TA94 strains which were extremely sensitive to detect DNA cross linking agents.

摘要

阿克拉霉素A无致突变性,而大多数蒽环类药物如柔红霉素和阿霉素在沙门氏菌试验中具有高度致突变性。但其衍生物N-去甲基阿克拉霉素A具有致突变性。同样,阿克拉霉素A的水解产物阿克拉文无致突变性,但N-去甲基阿克拉文具有致突变性。N-甲基柔红霉素仅表现出微弱的致突变性,而N-二甲基柔红霉素无致突变性。因此,蒽环类糖苷的氨基部分被认为是诱变作用所必需的。博来霉素对大多数沙门氏菌测试菌株如TA98、TA100和TA92以及大肠杆菌菌株WP2/uvrA无致突变性。博来霉素对沙门氏菌TA102和TA94菌株有微弱的致突变性,这两种菌株对检测DNA交联剂极为敏感。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验